home

Health Tip: Setting Goals for a Healthier Lifestyle

Healthdrugs2016-03-25 10:07 Read   93

 If you're at risk for type 2 diabetes, making some lifestyle changes can help you keep the disease at bay.

Scientists have identified the molecules most capable of fighting prostate cancer

Frontiersciencealert2016-03-25 09:48 Read   92

Better than chemotherapy.

Bayer looks to protect blockbuster Eylea franchise with $130M Regeneron pact

TrendBayer2016-03-25 09:42 Read   131

Bayer is gambling up to $130 million to lay claim to half the ex-U.S. profits that may lie ahead for one of Regeneron's ($REGN) next-gen combination eye drugs, a successor to their blockbuster Eylea franchise. 

FDA takes important step to increase the development of, and access to, abuse-deterrent opioids

RegulatorFDA2016-03-25 09:17 Read   181

The U.S. Food and Drug Administration today issued a draft guidance intended to support industry in their development of generic versions of approved opioids with abuse-deterrent formulations (ADF) while ensuring that generic ADF opioids are no less abuse-deterrent than the brand-name drug.

Top 5 articles on fibromyalgia highlight pain, fatigue, disability

CommentsHEALIO2016-03-24 14:34 Read   105

Recently published research on fibromyalgia has focused on perceptions about pain and fatigue, and the prevalence of disability among patients with fibromyalgia. Other research highlighted treatment strategies for patients with fibromyalgia and identified subsets of patients who may have varying degrees of symptoms.

Envisia Gets $16.5M More to Back Extended-Release Eye Drugs

TrendXconomy2016-03-24 14:17 Read   119

Investors in Envisia Therapeutics are pumping $16.5 million more into the eye drug developer to carry the company’s lead candidate, a potential glaucoma treatment, through mid-stage clinical trials.

Valneva launches a Commercial Operation in the UK

TrendFirstword2016-03-24 14:11 Read   120

Valneva, a specialist vaccines company with offices in France, Austria, Sweden, Canada and the US, has now established a Commercial Operation in the UK. The company already has a manufacturing site in Livingston, Scotland.

Analyst slashes Entresto sales forecast in half as skeptical heart docs hobble uptake

TrendFiercepharma2016-03-24 13:52 Read   168

When Novartis ($NVS) execs predicted big things for their Entresto launch, they didn't promise it would happen overnight.

Cellceutix Pipeline Continues to Hit Milestone After Milestone

TrendCellceutix2016-03-24 11:10 Read   122

Cellceutix Corp. (CTIX:OTCMKTS), a small-cap biotech company focused on developing novel compounds for a range of applications, has released a flurry of announcements over the past five weeks as several of its pipeline drugs cleared regulatory hurdles and readied for their next milestones. The series of press releases on three different Cellceutix experimental drugs put a charge in the stock, sending it upward in a matter of a few days by more than 57% to a high of $1.81/share on Tuesday, March 21.

IQWiG unimpressed with Cosentyx in two new indications

RegulatorPMLIVE2016-03-24 10:27 Read   165

Germany's cost regulator has decided there is no evidence for an added benefit of Novartis's Cosentyx in ankylosing spondylitis and psoriatic arthritis compared to established drugs.

Amgen and UCB's romosozumab hits goals in male osteoporosis

TrendAmgen2016-03-24 10:17 Read   175

A phase III study of Amgen and UCB's romosozumab in men with osteoporosis has met its objectives, adding to earlier positive data in post-menopausal women.

Health Tip: Preparing for a Pedicure

HealthMedical2016-03-24 10:04 Read   100

Getting a pedicure may seem routine, but without precautions you may be putting your health at risk.